Duke M. Fitch
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Synthetic Organic Chemistry Methods, Asymmetric Synthesis and Catalysis, Hepatitis C virus research, Quinazolinone synthesis and applications, HIV/AIDS drug development and treatment
Most-Cited Works
- → Application of Complex Aldol Reactions to the Total Synthesis of Phorboxazole B(2000)198 cited
- → 3-(1,1-Dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase(2006)160 cited
- → Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor–Prolyl Hydroxylase Inhibitor for Anemia(2017)91 cited
- → Asymmetric Synthesis of Phorboxazole B—Part I: Synthesis of the C20-C38 and C39-C46 Subunits(2000)85 cited
- → Asymmetric Synthesis of Phorboxazole B—Part II: Synthesis of the C1-C19 Subunit and Fragment Assembly(2000)66 cited
- → Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295(2010)64 cited
- → Enantioselective Synthesis of the Elaiophylin Aglycon(1997)59 cited
- → Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase(2009)45 cited
- → Tremorgenic Indole Alkaloids. 9. Asymmetric construction of an Advanced F-G-H-ring Lactone precursor for the Synthesis of Penitrem D(1995)41 cited
- → A Highly Efficient, Asymmetric Synthesis of Benzothiadiazine-Substituted Tetramic Acids: Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase(2005)35 cited